These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
457 related articles for article (PubMed ID: 23844368)
1. Recent developments in nanoparticle-based siRNA delivery for cancer therapy. Lee JM; Yoon TJ; Cho YS Biomed Res Int; 2013; 2013():782041. PubMed ID: 23844368 [TBL] [Abstract][Full Text] [Related]
2. Lipid nanoparticles for short interfering RNA delivery. Leung AK; Tam YY; Cullis PR Adv Genet; 2014; 88():71-110. PubMed ID: 25409604 [TBL] [Abstract][Full Text] [Related]
3. Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach. Mahmoodi Chalbatani G; Dana H; Gharagouzloo E; Grijalvo S; Eritja R; Logsdon CD; Memari F; Miri SR; Rad MR; Marmari V Int J Nanomedicine; 2019; 14():3111-3128. PubMed ID: 31118626 [TBL] [Abstract][Full Text] [Related]
4. Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics. Kulkarni JA; Witzigmann D; Chen S; Cullis PR; van der Meel R Acc Chem Res; 2019 Sep; 52(9):2435-2444. PubMed ID: 31397996 [TBL] [Abstract][Full Text] [Related]
5. Lipid-based siRNA Delivery Systems: Challenges, Promises and Solutions Along the Long Journey. Sarisozen C; Salzano G; Torchilin VP Curr Pharm Biotechnol; 2016; 17(8):728-40. PubMed ID: 27033509 [TBL] [Abstract][Full Text] [Related]
6. Nanoparticle delivery systems for siRNA-based therapeutics. Li J; Xue S; Mao ZW J Mater Chem B; 2016 Nov; 4(41):6620-6639. PubMed ID: 32263517 [TBL] [Abstract][Full Text] [Related]
7. Nanoparticles for siRNA-Based Gene Silencing in Tumor Therapy. Babu A; Muralidharan R; Amreddy N; Mehta M; Munshi A; Ramesh R IEEE Trans Nanobioscience; 2016 Dec; 15(8):849-863. PubMed ID: 28092499 [TBL] [Abstract][Full Text] [Related]
8. Nanoparticle-based delivery system for application of siRNA in vivo. Wang Y; Li Z; Han Y; Liang LH; Ji A Curr Drug Metab; 2010 Feb; 11(2):182-96. PubMed ID: 20359287 [TBL] [Abstract][Full Text] [Related]
9. Rigid nanoparticle-based delivery of anti-cancer siRNA: challenges and opportunities. Wang Z; Liu G; Zheng H; Chen X Biotechnol Adv; 2014; 32(4):831-43. PubMed ID: 24013011 [TBL] [Abstract][Full Text] [Related]
17. Nanoparticle-siRNA: A potential cancer therapy? Young SW; Stenzel M; Yang JL Crit Rev Oncol Hematol; 2016 Feb; 98():159-69. PubMed ID: 26597018 [TBL] [Abstract][Full Text] [Related]
18. Functional nanostructures for effective delivery of small interfering RNA therapeutics. Hong CA; Nam YS Theranostics; 2014; 4(12):1211-32. PubMed ID: 25285170 [TBL] [Abstract][Full Text] [Related]
19. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma. Varshosaz J; Farzan M World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089 [TBL] [Abstract][Full Text] [Related]
20. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges. Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]